Norman Swan was talking about this on CoronaCast late last week. The research 
was yet to be peer reviewed, but he referred to his training in giving 
intramuscular injections, where you had to draw back to check that there was no 
blood.
Peter

> On 5 Jul 2021, at 12:35 pm, Jan Whitaker <[email protected]> wrote:
> 
> Interesting! Someone who I think was a nurse, can't remember who, was 
> appalled that the injections were NOT being pulled back to be sure there was 
> no blood. They were watching the endless TV videos of injections being given. 
> From this article, it seems they were on to something.
> 
> Jan
> 
> On 5/07/2021 11:05 am, Kim Holburn wrote:
>> https://www.biorxiv.org/content/10.1101/2021.06.29.450356v1.abstract
>> 
>> Thrombocytopenia and splenic platelet directed immune responses after 
>> intravenous ChAdOx1 nCov-19 administration.
>> 
>>> Vaccines against SARS-CoV-2 are based on a range of novel vaccine 
>>> platforms, with adenovirus-based approaches (like ChAdOx1 nCov-19) being 
>>> one of them. Recently a rare and novel complication of SARS-CoV-2 targeted 
>>> adenovirus vaccines has emerged: thrombosis with thrombocytopenia syndrome 
>>> (TTS). TTS is characterized by low platelet counts, clot formation at 
>>> unusual anatomic sites and platelet-activating PF4-polyanion antibodies 
>>> reminiscent of heparin-induced thrombocytopenia. Here, we employ /in vitro/ 
>>> and /in vivo/ models to characterize the possible mechanisms of this 
>>> platelet-targeted autoimmunity. We show that intravenous but not 
>>> intramuscular injection of ChAdOx1 nCov-19 triggers platelet-adenovirus 
>>> aggregate formation and platelet activation. After intravenous injection, 
>>> these aggregates are phagocytosed by macrophages in the spleen and platelet 
>>> remnants are found in the marginal zone and follicles. This is followed by 
>>> a pronounced B-cell response with the emergence!
  of circulating antibodies binding to platelets. Our work contributes to the 
understanding of TTS and highlights accidental intravenous injection as 
potential mechanism for post-vaccination TTS. Hence, safe intramuscular 
injection, with aspiration prior to injection, could be a potential preventive 
measure when administering adenovirus-based vaccines.
>> 
> _______________________________________________
> Link mailing list
> [email protected]
> https://mailman.anu.edu.au/mailman/listinfo/link


Internet Technology Services
24A Speight Street Thornbury
Victoria 3071 Australia

Mobile 0425 733 532




_______________________________________________
Link mailing list
[email protected]
https://mailman.anu.edu.au/mailman/listinfo/link

Reply via email to